ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Tuesday reported a loss of $34.6 million in its third quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 94 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 91 cents per share.
The biotechnology company posted revenue of $14.7 million in the period.
Regenxbio shares have declined 10% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $37.62, a fall of 46% in the last 12 months.